Navigation Links
FDA Clears Cellectar's IND Application for Lead Drug Candidate
Date:3/3/2009

(131)I-CLR1404 to Enter Clinical Trials

MADISON, Wis., March 3 /PRNewswire/ -- Cellectar, Inc., a privately held radiopharmaceuticals company that designs and develops products to detect, treat and monitor human cancers, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for its (131)I-CLR1404 drug candidate for testing in patients with advanced solid malignancies. The company expects to begin phase I clinical studies in the second quarter of 2009.

The first phase I study will enroll up to 9 patients and will include drug dosimetry calculations and biodistribution assessments. The second phase I study will be a dose escalation study evaluating the Maximum Tolerated Dose (MTD) of (131)I-CLR1404 in patients with advanced solid malignancies; both studies will be performed at four leading U.S. medical centers.

Cellectar's President and CEO, Bill Clarke, M.D., commented, "We are extremely pleased to have received FDA clearance allowing us to advance our lead product candidate into human clinical studies. Further, we are hopeful that this novel anti-cancer compound, selectively retained by cancer cells, may provide benefit to solid tumor patients with few therapeutic options."

About (131)I-CLR1404

Cellectar's (131)I-CLR1404 is a small-molecule, phospholipid ether analog that combines lipid-like properties with a cancer therapeutic beta-emitting radioisotope. Cellectar believes that this compound will benefit individuals with cancer due to its selective retention and accumulation in malignant cells versus nonmalignant cells. Preclinical animal studies demonstrated that (131)I-CLR1404 significantly slowed the growth of malignant solid tumors and resulted in improved survival. Non-radiolabeled CLR1404 proved safe at doses greater than 1000x the anticipated human dose.

About
'/>"/>

SOURCE Cellectar, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Global Gene Map Clears New Milestone
2. FDA Clears MDN-CGS(R) Intravenous Insulin Dosing Software
3. American Medical Association Clears Path for Adenoviral Conjunctivitis - Pink Eye - Detector
4. Congress Clears the Way for National CPR and AED Awareness Week
5. FDA Clears Cellsearch(TM) Circulating Tumor Cell Test for Monitoring Metastatic Prostate Cancer Patients
6. ClearScript Offers Innovative Medication Therapy Management Program to Employee Health Plans
7. Alzheimers vaccine clears plaque but has little effect on learning and memory impairment
8. Genetic Information Nondiscrimination Act clears Senate
9. Dutch Authorize Manufacture of Vaccinogens New Cancer Vaccine; License Clears Path to European Production, Final FDA Trial
10. FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression
11. FDA Clears the DPL (Deep Penetrating Light) Therapy System for Over-the-Counter - Home Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... (BUSM) report variants in a new gene, PLXNA4, which ... The discovery of this novel genetic association may lead ... These findings appear in the Annals of Neurology ... affecting 5.4 million Americans including 13 percent of people ... of people age 85 and older. Genetic factors account ...
(Date:7/28/2014)... The University of Texas Health Science Center at San Antonio, ... combination of pills that cures 9 of 10 hepatitis C ... with or without ribavirin, cured 93 percent of patients in ... the study published today in The Lancet . ... Eric Lawitz, M.D., clinical professor in the School of Medicine ...
(Date:7/28/2014)... The Wireline Services Market in Europe report defines ... and forecast of revenue. The Wireline services market in Europe ... to $2.4 billion by 2019, at a CAGR of 11.2%, ... the Wireline Services Market in Europe report, to get an ... glimpse of the segmentation in the European Wireline Services market, ...
(Date:7/28/2014)... The North America Carotenoids & Antioxidants Market report defines ... with analysis and forecast of revenue. This market is estimated ... million by 2018, at a CAGR of 7.1% from 2013 ... America Carotenoids & Antioxidants Market report to get an idea ... of the segmentation in the market, and is supported by ...
(Date:7/28/2014)... A common inflammatory muscle disorder that causes pain ... risk for heart attack and stroke, new ... patients with polymyalgia rheumatica are more likely to ... blood vessels. Doctors should carefully manage the vascular ... reduce their risk for complications, the study authors ...
Breaking Medicine News(10 mins):Health News:Researchers identify potential biomarker for AD 2Health News:New pill regimens published in The Lancet cure hardest-to-treat hepatitis C patients 2Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 2Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 3Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 4Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Inflammatory Muscle Disorder May Raise Risk for Heart Attack, Stroke 2
... Relationship Expected to Result in Improved Nursing Productivity in the ... ... Panama City, Fla. (PRWEB) February 27, 2009 -- iSirona®, an ... announced that it has signed an agreement with NxStage Medical, ...
... proud to announce the launch of searchjointpain.com, a new informational Web site ... , ... Potomac, MD (PRWEB) February 27, 2009 -- The Healthy Living Network, ... of searchjointpain.com , a new informational Web site devoted to all ...
... MS treatment; more than 130 clinical trials are under way. ... ... patients with multiple sclerosis is gaining traction through a number of ... Sclerosis Society , which is celebrating National MS Awareness Week on ...
... commitment to marketing spend Hallmark Cards today unveiled its plans for a ... ,Cards For A Cure™, campaign. This will be the third year ... to two breast cancer charities by the end of its 2009 Mother,s ... ...
... Leading heath insurance fund Medibank Private has released a list of the ... ... February 27, 2009 -- A hospital bill of $364,859 for complex bowel ... expensive health insurance benefit claims made by members of the ...
... Woman,s Measurements , New web-based research has quantified the ... researchers manipulated the features of one woman into 243 ... hip and waist widths. Then more than 34,000 people ... face remained exactly the same in all of the ...
Cached Medicine News:Health News:iSirona Signs Reference Selling Agreement with NxStage 2Health News:Healthy Living Network Announces Launch of New Joint Pain Web Site 2Health News:MS Research, Funding Speed Development of New Therapies 2Health News:Hallmark Cards Increases Investment In Cards For a Cure™ with Major Advertising and PR Campaign for Mother's Day 2009 2Health News:Hallmark Cards Increases Investment In Cards For a Cure™ with Major Advertising and PR Campaign for Mother's Day 2009 3Health News:Health Insurance Claims Top $2 Million Mark 2Health News:Health Insurance Claims Top $2 Million Mark 3Health News:Plastic and reconstructive surgery ... in brief 2
(Date:7/28/2014)... July 28, 2014  TNI BioTech, Inc. (OTCQB: ... focused on the development, marketing and distribution of ... definitive proxy materials with the Securities and Exchange ... of Shareholders to be held on Thursday, September ... The record date for determining those shareholders eligible ...
(Date:7/28/2014)... -- ResMed (NYSE: RMD ), an innovator and ... breathing and other chronic respiratory conditions, has won a ... Taiwanese medical device manufacturer APEX Medical Corp. (APEX), prohibiting ... and 220 masks.  The judgment was entered by the ... is appealable, and applies throughout Germany.  ...
(Date:7/28/2014)... -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) announced ... quarter and year-to-date 2014 financial results on Monday, August ... markets. The earnings press release will be accessible through ... www.anipharmaceuticals.com . Arthur S. Przybyl , ... Arnold , Vice President and Chief Financial Officer, also ...
Breaking Medicine Technology:TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2
... announces that a new market research report is ... Global Medical Ultrasound Equipment Industry ... analyzes the worldwide markets for Medical Ultrasound Equipment ... segments: Radiology, Cardiology, Obstetrics/Gynecology, Vascular, and Other (Other ...
... announces that a new market research report is ... Iodine Industry http://www.reportlinker.com/p0397812/Global-Iodine-Industry.html ... markets for Iodine in Metric Tons by the ... Human Health, Stabilizers, Optical Polarizing Film (OPF), and ...
Cached Medicine Technology:Reportlinker Adds Global Medical Ultrasound Equipment Industry 2
... IOL with OptiEdge offers design innovations that ... and excellent handling. The biostable acrylic material ... of vacuoles; the patented OptiEdge is designed ... 360 degrees of contact with the posterior ...
... an intraocular lens that doesn't stop ... natural human lens, the new ACRYSOF® ... high-energy blue light. But while it ... your patient's view. That's just as ...
Single-Piece PMMA Intraocular Lenses....
Single-Piece PMMA Intraocular Lenses....
Medicine Products: